Different GLP-1 therapies could be tailored to patients' individual metabolic needs

Different varieties and doses of GLP-1 medications can have meaningful differences in how they address heart and metabolic health issues, according to new research led by the Perelman School of Medicine at the University of Pennsylvania.

Through an analysis of data from 19 randomized controlled trials, the researchers believe their work points to possible precision medicine applications of GLP-1s beyond weight loss.

Their work is published in Diabetes, Obesity, and Metabolism. ...